Liquid Biopsy to Enable Diagnostics and Monitoring for Immune-mediated Lymphoproliferative Disorders

Clinical trial NCT05803616 · UNKNOWN

Trial details

NCT number: NCT05803616
Sponsor: University Hospital, Geneva
Status: UNKNOWN
Study type: OBSERVATIONAL

Lymphoproliferative Disorders Lymphoproliferative Disorder Following Transplantation

Start date: 2022-05-23
Primary completion: 2023-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.